These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France. Leroy S; Benzaquen J; Mazzetta A; Marchand-Adam S; Padovani B; Israel-Biet D; Pison C; Chanez P; Cadranel J; Mazières J; Jounieaux V; Cohen C; Hofman V; Ilie M; Hofman P; Marquette CH; BMJ Open; 2017 Dec; 7(12):e018884. PubMed ID: 29282271 [TBL] [Abstract][Full Text] [Related]
3. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study. Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P; Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919 [TBL] [Abstract][Full Text] [Related]
4. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study. Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC; Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167 [TBL] [Abstract][Full Text] [Related]
5. [Why screen for lung cancer in patients with arterial disease?]. Lederlin M; Trédaniel J; Priollet P J Mal Vasc; 2015 Dec; 40(6):359-64. PubMed ID: 26276562 [TBL] [Abstract][Full Text] [Related]
6. Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. Crawford EL; Levin A; Safi F; Lu M; Baugh A; Zhang X; Yeo J; Khuder SA; Boulos AM; Nana-Sinkam P; Massion PP; Arenberg DA; Midthun D; Mazzone PJ; Nathan SD; Wainz R; Silvestri G; Tita J; Willey JC BMC Pulm Med; 2016 Jan; 16():16. PubMed ID: 26801409 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended. Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734 [TBL] [Abstract][Full Text] [Related]
8. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers. Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189 [TBL] [Abstract][Full Text] [Related]
9. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants]. Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664 [TBL] [Abstract][Full Text] [Related]
10. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S; Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M; Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561 [TBL] [Abstract][Full Text] [Related]
12. Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Conen D; Everett BM; Kurth T; Creager MA; Buring JE; Ridker PM; Pradhan AD Ann Intern Med; 2011 Jun; 154(11):719-26. PubMed ID: 21646555 [TBL] [Abstract][Full Text] [Related]
13. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A; Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer. Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol. Boulate D; Fidelle M; Caramella C; Issard J; Planché O; Pradère P; Garelik D; Hache O; Lamrani L; Zins M; Beaussier H; Chatellier G; Fadel E; Zitvogel L; Besse B; Mercier O BMJ Open; 2022 Dec; 12(12):e067191. PubMed ID: 36572501 [TBL] [Abstract][Full Text] [Related]
17. Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature. Bintein F; Yannoutsos A; Chatellier G; Fontaine M; Damotte D; Paterlini-Bréchot P; Meyer G; Duchatelle V; Marini V; Schwering KL; Labrousse C; Beaussier H; Zins M; Salmeron S; Lajonchère JP; Priollet P; Emmerich J; Trédaniel J J Med Vasc; 2021 Apr; 46(2):53-65. PubMed ID: 33752847 [TBL] [Abstract][Full Text] [Related]
18. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial. Guldbrandt LM Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876 [TBL] [Abstract][Full Text] [Related]
19. LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol. Delva F; Laurent F; Paris C; Belacel M; Brochard P; Bylicki O; Chouaïd C; Clin B; Dewitte JD; Le Denmat V; Gehanno JF; Lacourt A; Margery J; Verdun-Esquer C; Mathoulin-Pélissier S; Pairon JC BMJ Open; 2019 Mar; 9(3):e025026. PubMed ID: 30904859 [TBL] [Abstract][Full Text] [Related]
20. Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening population. Jobst BJ; Weinheimer O; Trauth M; Becker N; Motsch E; Groß ML; Tremper J; Delorme S; Eigentopf A; Eichinger M; Kauczor HU; Wielpütz MO Eur Radiol; 2018 Feb; 28(2):807-815. PubMed ID: 28884215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]